Scale -


  • Revenue is 1500 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; 5 Year CAGR is 20 %
  • Ebitda is 386 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; 5 Year CAGR is 25 %
  • PAT is 194 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 40 %
  • Quarterly Revenue is 411 Rs Cr; Continuous Growth over 3 Quarters
  • PBT is 50.55 Rs Cr; 5 Year CAGR is 36 %

Profitability -


  • PAT Margin is 12.94 %; 5 Year CAGR is 17 %; Annual Decline is -16 %; Continuous Decline over 3 years

Return -


  • ROCE is 13.81 %; Continuous Decline over 3 years
  • ROA is 8.14 %; Continuous Decline over 3 years
  • ROE is 12.56 %; Continuous Decline over 3 years
  • Asset Turnover is 70 %; Continuous Decline over 3 years

Efficiency -


  • Operating cash flow is 268 Rs Cr; Continuous Growth over 3 years
  • Current Ratio is 3.02; in Top Quartile; Annual Decline is -33 %
  • Quick Ratio is 2.85; in Top Quartile; 5 Year CAGR is 21 %; Annual Decline is -34 %

Solvancy -


  • Debt/Equity is 0.33; 5 Year CAGR is -34 %; Annual Growth is 38 %; Continuous Growth over 3 years
  • Long term Debt is 501 Rs Cr; Annual Growth is 56 %; Continuous Growth over 3 years; in Top Quartile
  • Total Debt is 509 Rs Cr; Annual Growth is 56 %; Continuous Growth over 3 years
  • Contingent Liabilities is 4.93 Rs Cr; 5 Year CAGR is 36 %

Quality -


  • Change in Inventories/Total Expenses is -1 %; Annual Decline is -248 %; Continuous Decline over 3 years; in Bottom Quartile
  • Operating cashflow/PAT is 138 %; Continuous Growth over 3 years; 5 Year CAGR is -15 %
  • Exceptional Items/PBT is -2 %; in Bottom Quartile
  • Current Tax/PAT is 33 %; Continuous Growth over 3 years

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Jupiter Life Line Q2FY27 Results: EBITDA up 16%, net profit dips 2%
Jupiter Life Line Hospitals Limited Just Missed EPS By 76%: Here's What Analysts Think Will Happen Next
Buy Jupiter Life Line Hospitals; target of Rs 330: Prabhudas Lilladher
Buy Jupiter Life Line Hospitals; target of Rs 340: Choice Institutional Equities
Jupiter Life Line Hospitals (NSEI:JLHL)
Jupiter Life Line Hospitals agrees to buy land in Pune for INR 1.50 billion
Jupiter Life Line Hospitals approves ?150cr for acquiring land in Pune
Jupiter Life Line Hospitals Ltd (NSE:JLHL) (Q2 2027) Earnings Call Highlights: Strong Margins, ...
Jupiter Life Line Hospitals to acquire 2.8 acres of land in Pune
Earnings call transcript: Jupiter Life Line Hospitals posts strong Q2 2026 results By Investing.com
Jupiter Hospital Q2FY27 slides: revenue rises, expansion weighs on profit By Investing.com
Jupiter Life Line expects margin improvement as Dombivli hospital moves towards break-even
Jupiter Life Line Hospitals JLHL Q2 FY27 Earnings Call Audio
Jupiter Life Line Hospitals JLHL Q2 FY27 Results Newspaper Publication
Jupiter Life Line Hospitals JLHL Board Meeting October 2026
Jupiter Life Line Hospitals Ltd. Estimates – NSE:JLHL
Jupiter Life Line Hospitals Q2 Revenue Rises to ?4.56 Billion vs ?3.94 Billion YoY
Jupiter Life Line Hospitals (JLHL.NS) Ticks Up 1.05% to ?246.45 as Buyers Defend ?234 Support
Jupiter Life Line Hospitals rises on entering into hypothecation agreement with HDFC Bank
Jupiter Life Line Hospitals JLHL Rs 500 Cr HDFC Bank Term Loan
Jupiter Life Line hospitals secures ?500 crore term loan from HDFC Bank
Jupiter Life Line Hospitals Signs Hypothecation Agreement with HDFC Bank for ?500 Crore Term Loan Facility
Jupiter Life Line Hospitals Ltd Entered Into Hypothecation Agreement With HDFC Bank For Financing Capital Expenditure Requirement
Jupiter Life Line Hospitals (JLHL.NS) Climbs 3.09% to ?247.05, Tests Mid-Range Resistance
Jupiter Life Line Hospitals Share Price and Sector Analysis
Jupiter Life Line Hospitals to host Q2FY27 earnings call on Oct 26